Cephalon Inc., the maker of the sleep-disorder drug Provigil, has agreed to buy closely held Zeneus Pharma Ltd. of the United Kingdom for about $360 million in cash to expand sales of cancer drugs in Europe.
The acquisition of Oxford, England-based Zeneus Holdings, the parent company of Zeneus Pharma, probably will be completed in the first quarter of next year at the latest, Pennsylvania-based Cephalon said Tuesday.
Cephalon has a manufacturing facility in Salt Lake City.
The transaction would be Cephalon's third this year to bolster its offerings of cancer drugs.
Consumer confidence
A better hiring outlook and lower gas prices pushed a measure of U.S. consumer confidence to its highest level in four and a half years.
5th iPhone app
Clayton Ward, a 10th-grader from West Jordan,has created five apps for the Apple operating systems.
poorer people charitable
A 2009 study showed the poor give a higher percentage of their income to charity than rich people.
- Studies try to find why poorer people are...
- Wasting Money: Designer pet clothing and 59...
- West Jordan teen releases 5th iPhone app
- Top 10 poorest states in America
- 18 cheap ways to captivate teens
- House GOP plans summer tax cut vote
- Law school grad pays off $114,460 in debt...
- KSL TV news icon Bruce Lindsay calls it a career
Subscribe
Mobile
RSS
- Billboard battle heats up as company...
29 - Utah County cities, businesses claim... 15
- Studies try to find why poorer people... 14
- KSL TV news icon Bruce Lindsay calls it... 12
- Millennials love to spend money they... 11
- Rising health care costs burden families 10
- 'Greecing' the wheels: U.S. financial... 10
- UTA's plans to end free bus service... 7
DeseretNews.com encourages a civil dialogue among its readers. We welcome your thoughtful comments.
— About comments